Print full article
The tests most commonly used to investigate men with symptoms suggestive of prostate cancer are rectal examination and the prostate-specific antigen (PSA) blood test. To perform a , the doctor inserts a gloved, lubricated finger into the rectum (back passage) and feels the prostate gland with his or her finger for localised hardness or nodules. For the PSA test, blood is taken and sent to a clinical laboratory. There the blood is examined for an increased level of the serum marker associated with prostate or cancer.
While the PSA level is raised in up to eighty percent of prostate cancers, an abnormal result is not a cancer diagnosis. In fact, two-thirds of men with a raised serum PSA level do not have prostate cancer, although other abnormalities requiring treatment may be the cause of a raised PSA results. Rectal examination and PSA measurement can also assist in the early detection of benign prostatic hypertrophy (BPH). The current Australian position about the use of PSA to screen men without symptoms for prostate cancer is explained under Screening/Adults 50+.
Should you have symptoms described previously, be sure to let your doctor know. If your PSA and/or rectal examination have normal results, your doctor can recommend when re-testing is appropriate. If your results are abnormal, the PSA result should be confirmed and may include a Free/Total PSA measurement. Your doctor may then recommend further tests, such as a transrectal ultrasound-guided . This procedure allows a doctor to take tissue from the prostate for further study. It may be necessary to stop taking certain medicines up to ten days beforehand.
Once a diagnosis of prostate cancer is made, doctors may use a variety of tests to monitor the cancer, determine treatment options, and evaluate the effectiveness of a chosen course of treatment. In addition to using rectal examination and PSA for this purpose, tests using X-ray, ultrasound, and tissue sampling may be used.